Skip to content
  • Follow Us
CarboHyde
  • Home
  • Cyclodextrin Masterclass VI
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Listen to the Carbohydrate Chronicles Podcast!
    • Carbohydrate Chronicles Season 2 / Ep 1 Application beyond pharma
    • Carbohydrate Chronicles Season 2 / Ep 2 Cyclodextrin in biologic formulation
    • Carbohydrate Chronicles Season 2 / Ep 3 Safety and toxicity
    • Carbohydrate Chronicles Season 2 / Ep 4 Cyclodextrin in food and nutraceuticals
  • Home
  • Cyclodextrin Masterclass VI
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Listen to the Carbohydrate Chronicles Podcast!
    • - Carbohydrate Chronicles Season 2 / Ep 1 Application beyond pharma
    • - Carbohydrate Chronicles Season 2 / Ep 2 Cyclodextrin in biologic formulation
    • - Carbohydrate Chronicles Season 2 / Ep 3 Safety and toxicity
    • - Carbohydrate Chronicles Season 2 / Ep 4 Cyclodextrin in food and nutraceuticals
CarboHyde
  • Home
  • Cyclodextrin Masterclass VI
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Listen to the Carbohydrate Chronicles Podcast!
    • Carbohydrate Chronicles Season 2 / Ep 1 Application beyond pharma
    • Carbohydrate Chronicles Season 2 / Ep 2 Cyclodextrin in biologic formulation
    • Carbohydrate Chronicles Season 2 / Ep 3 Safety and toxicity
    • Carbohydrate Chronicles Season 2 / Ep 4 Cyclodextrin in food and nutraceuticals

Co-Delivery of 8-Hydroxyquinoline Glycoconjugates and Doxorubicin by Supramolecular Hydrogel Based on α-Cyclodextrin and pH-Responsive Micelles for Enhanced Tumor Treatment

Nov 25, 2022Tamas Sohajdadrug deliverycancer, cancer research, formulation development

Two birds with one stone:
This study of the Silesian University of Technology and the Polish Academy of Sciences is close to our hearts as we both deal with glycoconjugates and cyclodextrin. They show the delivery of 8-Hydroxyquinoline Glycoconjugates and Doxorubicin using ACD-based hydrogel for enhanced tumor treatment.

Monika D. Gabriela Pastuch Piotr Kurcok 

See the full article here

Prev
Next
Developed by Shuttle Themes. Powered by WordPress.
  • Contact Us
  • LinkedIn
  • Twitter
  • Privacy Policy